Home
/
Inspire Medical Systems, Inc.
/
Financials
/
Quarterly
Inspire Medical Systems, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Inspire Medical Systems, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q4
2018
Dec 31, 2018
$16.56M
Feb 26, 2019
Q4
2018
Sep 30, 2018
$13.05M
Feb 26, 2019
Q3
2018
Sep 30, 2018
$13.05M
Nov 6, 2018
Q2
2018
Jun 30, 2018
$10.94M
Aug 7, 2018
Q4
2018
Jun 30, 2018
$10.94M
Feb 26, 2019
Q1
2018
Mar 31, 2018
$10.04M
Jun 7, 2018
Q4
2018
Mar 31, 2018
$10.04M
Feb 26, 2019
Q4
2018
Dec 31, 2017
$9.96M
Feb 26, 2019
Q4
2018
Sep 30, 2017
$7.27M
Feb 26, 2019
Q3
2018
Sep 30, 2017
$7.27M
Nov 6, 2018
Q2
2018
Jun 30, 2017
$6.04M
Aug 7, 2018
Q4
2018
Jun 30, 2017
$6.04M
Feb 26, 2019
Q4
2018
Mar 31, 2017
$5.30M
Feb 26, 2019
Q1
2018
Mar 31, 2017
$5.30M
Jun 7, 2018
Q4
2018
Dec 31, 2016
$16.43M
Feb 26, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$224.50M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$217.09M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$201.32M
May 5, 2025
Q3
2025
Sep 30, 2024
$203.19M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$195.89M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$164.01M
May 5, 2025
Q3
2024
Sep 30, 2023
$153.30M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$151.09M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$127.90M
May 7, 2024
Q3
2023
Sep 30, 2022
$109.19M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$91.39M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$69.38M
May 2, 2023
Q3
2022
Sep 30, 2021
$61.69M
Nov 1, 2022
Q2
2022
Jun 30, 2021
$52.96M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$40.35M
May 3, 2022
Q3
2021
Sep 30, 2020
$35.84M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$12.18M
Aug 3, 2021
Q1
2021
Mar 31, 2020
$21.35M
May 4, 2021
Q3
2020
Sep 30, 2019
$20.86M
Nov 2, 2020
Q2
2020
Jun 30, 2019
$18.03M
Aug 4, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$9.93M
Nov 3, 2025
Q2
2025
Jun 30, 2025
($3.59M)
Aug 4, 2025
Q3
2025
Jun 30, 2025
($3.59M)
Nov 3, 2025
Q2
2025
Mar 31, 2025
$2.99M
Aug 4, 2025
Q3
2025
Mar 31, 2025
$2.99M
Nov 3, 2025
Q1
2025
Mar 31, 2025
$2.99M
May 5, 2025
Q3
2025
Sep 30, 2024
$18.50M
Nov 3, 2025
Q3
2025
Jun 30, 2024
$9.79M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$9.79M
Aug 4, 2025
Q3
2025
Mar 31, 2024
($10.01M)
Nov 3, 2025
Q1
2025
Mar 31, 2024
($10.01M)
May 5, 2025
Q2
2025
Mar 31, 2024
($10.01M)
Aug 4, 2025
Q3
2024
Sep 30, 2023
($8.54M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($11.95M)
Aug 6, 2024
Q3
2024
Jun 30, 2023
($11.95M)
Nov 4, 2024
Q3
2024
Mar 31, 2023
($15.42M)
Nov 4, 2024
Q1
2024
Mar 31, 2023
($15.42M)
May 7, 2024
Q2
2024
Mar 31, 2023
($15.42M)
Aug 6, 2024
Q3
2023
Sep 30, 2022
($16.85M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($14.49M)
Aug 1, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$9.64M
Nov 3, 2025
Q2
2025
Jun 30, 2025
($3.32M)
Aug 4, 2025
Q1
2025
Mar 31, 2025
($1.49M)
May 5, 2025
Q3
2025
Sep 30, 2024
$14.32M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$5.10M
Aug 4, 2025
Q1
2025
Mar 31, 2024
($15.22M)
May 5, 2025
Q3
2024
Sep 30, 2023
($13.47M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($16.60M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($19.50M)
May 7, 2024
Q3
2023
Sep 30, 2022
($17.19M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($14.01M)
Aug 1, 2023
Q1
2023
Mar 31, 2022
($16.06M)
May 2, 2023
Q3
2022
Sep 30, 2021
($9.80M)
Nov 1, 2022
Q2
2022
Jun 30, 2021
($12.54M)
Aug 2, 2022
Q1
2022
Mar 31, 2021
($15.69M)
May 3, 2022
Q3
2021
Sep 30, 2020
($9.89M)
Nov 2, 2021
Q2
2021
Jun 30, 2020
($22.81M)
Aug 3, 2021
Q1
2021
Mar 31, 2020
($16.44M)
May 4, 2021
Q3
2020
Sep 30, 2019
($8.65M)
Nov 2, 2020
Q2
2020
Jun 30, 2019
($8.18M)
Aug 4, 2020